Related Experiment Video
Updated: Jun 12, 2026
04:16
Whole Body Vibration Methods with Survivors of Polio
Published on: October 17, 2018
Management of postpolio syndrome
Henrik Gonzalez1, Tomas Olsson, Kristian Borg
1Division of Rehabilitation Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden. henrik.gonzales@telia.com
The Lancet. Neurology
|May 25, 2010
Summary
Postpolio syndrome causes new or worsening muscle weakness and fatigue years after polio. Diagnosis involves identifying lower motor neuron disorders and excluding other causes, with rehabilitation focusing on tailored physical therapy.
Area of Science:
- Neurology
- Rehabilitation Medicine
Background:
- Postpolio syndrome (PPS) is a late complication following acute poliomyelitis.
- It manifests as progressive muscle weakness, fatigue, and pain after a stable period.
Purpose of the Study:
- To describe the characteristics, diagnosis, and management of postpolio syndrome.
- To provide guidance on rehabilitation strategies for PPS patients.
Main Methods:
- Diagnosis relies on identifying a lower motor neuron disorder supported by neurophysiological findings.
- Exclusion of other potential causes for new symptoms is crucial.
Main Results:
- Muscle weakness in PPS may stem from denervation exceeding reinnervation capacity.
- An inflammatory process is a potential, though unconfirmed, cause of denervation.
Conclusions:
- PPS management requires a multidisciplinary approach, emphasizing physiotherapy and tailored exercise.
- Patients should balance activity and rest, avoiding overuse of weak muscles, and may need orthoses or assistive devices.
Related Concept Videos
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...